Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognostic factors in a randomized multicenter clinical trial “DLBCL-2015”

Background. Diffuse large B-cell lymphoma (DLBCL) is one of the most common and aggressive tumors of the lymphatic system. Despite the frequency of occurrence, there is no single algorithm for treating DLBCL patients with poor prognostic factors. R-CHOP therapy does not allow achieving long-term com...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: M. O. Bagova, A. U. Magomedova, S. K. Kravchenko, Ya. K. Mangasarova, O. V. Margolin, E. S. Nesterova, L. G. Gorenkova, A. E. Misyurina, E. A. Fastova, F. E. Babaeva, K. A. Sychevskaya, S. M. Kulikov, Yu. A. Chabaeva, V. G. Savchenko
פורמט: Artigo
שפה:Russo
יצא לאור: ABV-press 2021-09-01
סדרה:Onkogematologiâ
נושאים:
diffuse large b-cell lymphoma
toxicity
effectiveness
r-da-epoch
r-mnhl-bfm-90
גישה מקוונת:https://oncohematology.abvpress.ru/ongm/article/view/491
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים